Ingenza is delighted to announce the appointment of Masha Kononov to head up the company’s business development activities in North America. Masha will commence her new full-time position at the end of October, joining the Ingenza team at the Recent Advances in Fermentation Technology conference in Florida.
Masha has over 25 years of experience in life sciences business development and R&D in the biotechnology and pharmaceuticals sectors. She has worked with a wide range of companies – from start-ups to CDMOs – located all over the world, most recently holding senior business development roles at prestigious companies Leukocare AG, Arcinova/Quotient Sciences and Catalent Pharma Solutions. As a result, Masha has accumulated a long track record of developing new territories, businesses and market-focused strategies, giving her in-depth knowledge of product development and manufacturing, as well as a profound understanding of current market needs.
Masha commented: “I am deeply passionate about science and building effective business relationships. I am looking forward to delivering on Ingenza’s high growth strategy by embarking upon successful new collaborations that accelerate the development of novel solutions to some of the environmental and health issues we are currently facing.”
Jaymin Amin, Chief Business Officer at Ingenza, added: “Masha is a creative, entrepreneurial and innovative scientific thinker, and is highly customer and team orientated. Her capabilities in establishing cross-functional relationships and directing team activities will be a great asset to Ingenza, and we are confident that Masha will turbo charge our business development within North America, establishing the region as a major driver for our accelerated growth strategy.”
For more information, visit www.ingenza.com.
